QUOTE AND NEWS
Stock Blog Hub  Jan 14  Comment 
Recently, Nektar Therapeutics (NKTR) announced preliminary results from the first stage of phase II study of its experimental ovarian cancer drug, NKTR-102. It has been observed that the drug, tested in women with platinum-resistant ovarian...
Samurai Trader  Jan 13  Comment 
It's kind of hard to say what kind of base this is, although I'm sure it has plenty of flaws, including a break  of the 50dma and a drop below the September gap. In hindsight, those were merely ruses to throw off traders, who probably dumped en...
StreetInsider.com  Jan 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Nektar+Therapeutics+%28NKTR%29+Announces+Positive+Results+from+NKTR-102+Phase+2/5240788.html for the full story.
PR Newswire  Jan 11  Comment 
SAN FRANCISCO, Jan. 11 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage cancer biotherapeutics company, today announced the appointment of Hoyoung Huh, M.D., Ph.D. to its board of directors. Dr. Huh is
Stock Blog Hub  Jan 7  Comment 
by Marc Lichtenfeld, Healthcare Expert Wednesday, January 6, 2010: Issue #1169 Now that we’re into the first week of 2010, let’s talk about the Super Bowl. But not the one in Miami, featuring a bunch of guys with pads and helmets....
PR Newswire  Jan 6  Comment 
SAN CARLOS, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 28th Annual J.P. Morgan Healthcare Conference in San Francisco at
PR Newswire  Nov 30  Comment 
SAN CARLOS, Calif., Nov. 30 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the promotion of Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer. Dr. Masuoka will report directly to Nektar's



Thank you for your suggestion


You may also be interested in articles related to Nektar Therapeutics (NKTR):
 
NKTR AT A GLANCE
 
 
Please install Flash Player to view this chart.
 
 
 
Please install Flash Player to view this chart.
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki